Figure 1: Hace1 deficiency accelerates pressure overload-induced heart failure. | Nature Communications

Figure 1: Hace1 deficiency accelerates pressure overload-induced heart failure.

From: HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress

Figure 1

(a) HACE1 mRNA expression is markedly increased in ischaemic and dilated cardiomyopathy (ICM and DCM) heart failure (HF) patient heart tissue compared with non-failing hearts (NF). Expression levels were normalized to HPRT and GAPDH mRNAs. n=15 per group. Control, non-failing heart. (b) Elevated Hace1 mRNA expression in sTAC mouse hearts compared with sham controls, expression levels were normalized to Hprt and Gapdh mRNAs. n=6–9 per group, P=0.004 (unpaired two-tailed Student’s t-tests). (cj) Hace1−/− and WT mice were subjected to sTAC or sham surgery and analysed 4 days after the operation. (ce) Echocardiographic measurement of (c) LV fractional shortening (FS=(LVEDD−LVESD)/LVEDD × 100%); (d) LV end-diastolic dimension (LVEDD) (mm) and (e) LV end-systolic dimension (LVESD) (mm) are shown. n=6–8 for each group. (f) Mortality rate of WT and Hace1−/− mice after sTAC is shown by Kaplan–Meier plots as the survival proportion of each cohort of mice. Survival incidence in mice over the indicated follow-up period is shown as the ratio of the number of mice survived/total mice analysed for each group. This represents 60% (12/20) for Hace1−/− sTAC mice, 84% (16/19) for Hace1+/+ sTAC mice and 100% (12/12) for both Hace1−/−and Hace1+/+ sham mice on day 4; P value as indicated (log-rank χ2-test). (g) Heart weight/body weight ratios (HW/BW) and (h) lung weight/body weight ratio (LW/BW) of WT and Hace1−/− mice 4 days after sTAC or sham surgery. n=15–21 for each group. (i) Representative haematoxylin and eosin staining transverse heart cross-sections showing myocyte cross-sectional area (scale bars, 20 μm). (j) Real-time RT–PCR analyses reveal a significant increase in the expression of the atrial natriuretic peptide gene (Nppa), a clinical biomarker for heart hypertrophy, in Hace1−/− sTAC heart; expression levels were normalized to Hprt and Gapdh mRNAs. n=6–9 per group. In all panels, error bars represent s.e.m., one-way analysis of variance were used to calculate P-values.

Back to article page